Literature DB >> 12818905

Islet transplant: an option for childhood diabetes?

E Hathout1, J Lakey, J Shapiro.   

Abstract

Careful assessment of the safety and efficacy of islet transplantation should guide the selection process of a small number of children with type 1 diabetes who may be eligible for the procedure--some of whom are already receiving immunosuppression because of a previous transplant, others who are scheduled to receive de novo islet alone transplantation because of a life threatening risk of hypoglycemia. The outcomes of these initial investigations are predicted to shape the future boundaries of islet transplantation, diabetes, and transplantation.

Entities:  

Mesh：

Year:  2003        PMID： 12818905      PMCID： PMC1763157          DOI： 10.1136/adc.88.7.591

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  44 in total

Review 1.  From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus.

Authors:  B Soria; A Skoudy; F Martín
Journal:  Diabetologia       Date:  2001-04       Impact factor: 10.122

Review 2.  The case for a role for postprandial glucose monitoring in diabetes management.

Authors:  J B Buse; M Hroscikoski
Journal:  J Fam Pract       Date:  1998-11       Impact factor: 0.493

3.  Diabetes. Childhood incidence.

Authors:  C Hodges
Journal:  Nurs Times       Date:  1997 Jan 1-7

4.  Blood glucose monitoring skills in children with Type I diabetes.

Authors:  A R Perwien; S B Johnson; D Dymtrow; J Silverstein
Journal:  Clin Pediatr (Phila)       Date:  2000-06       Impact factor: 1.168

5.  Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes.

Authors:  K A Matyka; L Wigg; S Pramming; G Stores; D B Dunger
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 6.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry.

Authors:  D W Gjertson; J M Cecka
Journal:  Pediatr Transplant       Date:  2001-02

8.  Repeated 2-deoxy-D-glucose-induced glucoprivation attenuates Fos expression and glucoregulatory responses during subsequent glucoprivation.

Authors:  N M Sanders; S Ritter
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

9.  The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes.

Authors:  H P Chase; T Lockspeiser; B Peery; M Shepherd; T MacKenzie; J Anderson; S K Garg
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

10.  Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience.

Authors:  Michael A Wallot; Michael Mathot; Magda Janssen; Tanja Hölter; Kilic Paul; Jean Paul Buts; Raymond Reding; Jean Bernard Otte; Etienne M Sokal
Journal:  Liver Transpl       Date:  2002-07       Impact factor: 5.799
View more
  10 in total

Review 1.  Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain.

Authors:  Esther S O'Sullivan; Arturo Vegas; Daniel G Anderson; Gordon C Weir
Journal:  Endocr Rev       Date:  2011-09-27       Impact factor: 19.871

2.  Noninvasive evaluation of the vascular response to transplantation of alginate encapsulated islets using the dorsal skin-fold model.

Authors:  Rahul Krishnan; Rajan P Arora; Michael Alexander; Sean M White; Morgan W Lamb; Clarence E Foster; Bernard Choi; Jonathan R T Lakey
Journal:  Biomaterials       Date:  2013-10-29       Impact factor: 12.479

Review 3.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 4.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

Review 5.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

Review 6.  Human pluripotent stem cell-derived insulin-producing cells: A regenerative medicine perspective.

Authors:  Adriana Migliorini; Maria Cristina Nostro; Julie B Sneddon
Journal:  Cell Metab       Date:  2021-04-06       Impact factor: 27.287

7.  Xenotransplantation of embryonic pig kidney or pancreas to replace the function of mature organs.

Authors:  Marc R Hammerman
Journal:  J Transplant       Date:  2010-12-28

8.  Engraftment of insulin-producing cells from porcine islets in non-immune-suppressed rats or nonhuman primates transplanted previously with embryonic pig pancreas.

Authors:  Marc R Hammerman
Journal:  J Transplant       Date:  2011-09-28

9.  An alternative sensor-based method for glucose monitoring in children and young people with diabetes.

Authors:  Julie Edge; Carlo Acerini; Fiona Campbell; Julian Hamilton-Shield; Chris Moudiotis; Shakeel Rahman; Tabitha Randell; Anne Smith; Nicola Trevelyan
Journal:  Arch Dis Child       Date:  2017-01-30       Impact factor: 3.791

10.  Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.

Authors:  Su-Jin Kim; Cuilan Nian; Doris J Doudet; Christopher H S McIntosh
Journal:  Diabetes       Date:  2008-12-10       Impact factor: 9.461
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.